Document is current
Any future updates will be listed below
-
Authors
Bae, Eun-Jin https://orcid.org/0000-0002-4369-7405
Ham, Sangwoo https://orcid.org/0000-0003-4569-2584
Jeong, Yeonwoo William https://orcid.org/0009-0005-1926-2857
Yang, Woo Seung
Shin, Jimin https://orcid.org/0009-0002-7921-4572
Lee, Won-Jae
Ahn, Woo Jung
Yoon, Ye-Seul
Lee, He-Jin
Lee, Sang Hwan https://orcid.org/0000-0003-4869-8885
Park, Sung-Hye https://orcid.org/0000-0002-8681-1597
Lee, Seung-Jae https://orcid.org/0000-0002-5155-5335
-
Funding
Funding for this research was provided by:
Ministry of Health and Welfare (RS-2024-00445582)
Korea Health Industry Development Institute (RS-2023-00266536)
- License Information
-
More Information
Article History
Received: 17 January 2025
Accepted: 16 December 2025
First Online: 30 January 2026
Competing interests
: S.J.L. is a co-founder and CEO of Neuramedy Co., Ltd. The other authors declare that they have no competing interests.
